Health insurer Anthem eases restrictions on Sarepta's Duchenne treatment

NEW YORK (Reuters) - Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary."
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news